Cite
APA Citation
Clausznitzer, D., Pichardo‐Almarza, C., Relo, A. L., van Bergeijk, J., van der Kam, E., Laplanche, L., Benson, N., & Nijsen, M. (2018). quantitative Systems Pharmacology Model for Alzheimer Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option. CPT: pharmacometrics & systems pharmacology, 7, 759–770. http://access.bl.uk/ark:/81055/vdc_100073686799.0x000006